Video Experimental Relacionado
Updated: Jul 6, 2026
06:44
Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography
Published on: April 13, 2018
Variantes genéticas asociadas con la trombosis venosa profunda
Irene D Bezemer1, Lance A Bare, Carine J M Doggen
1Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
JAMA
|March 20, 2008
Resumen
Este estudio identificó los polimorfismos clave de un solo nucleótido (SNP) vinculados al riesgo de trombosis venosa profunda (TVP). Las variaciones genéticas influyen significativamente en la probabilidad de que un individuo desarrolle TVP.
Área de la Ciencia:
- Genética La genética.
- Biología Molecular Biología Molecular
- Epidemiología La epidemiología.
Sus antecedentes:
- Los fundamentos genéticos de la trombosis venosa profunda (TVP) aún no se han aclarado por completo.
- La identificación de factores de riesgo genéticos es crucial para comprender la etiología y la prevención de la TVP.
Objetivo del estudio:
- Para identificar polimorfismos específicos de un solo nucleótido (SNP) asociados con un mayor riesgo de desarrollar TVP.
- Explorar la arquitectura genética que contribuye al riesgo trombótico.
Principales métodos:
- Utilizó tres grandes estudios de casos y controles (LETS, MEGA-1, MEGA-2) que involucraron a miles de participantes.
- Genotipó más de 19,000 SNPs genéticos y realizó un análisis de regresión logística para estimar las proporciones de probabilidades.
- Se aplicaron tasas de descubrimiento falso para evaluar rigurosamente la significación estadística de los SNPs identificados.
Principales resultados:
- Se identificaron tres SNPs fuertemente asociados con la TVP: rs13146272 en el CYP4V2, rs2227589 en el SERPINC1 y rs1613662 en el GP6.
- Se observó un aumento en el riesgo de TVP por alelo de riesgo para estos SNPs, con odds ratios que oscilan entre 1,15 y 1,29.
- Se descubrieron SNPs adicionales cerca de CYP4V2 asociados tanto con la TVP como con los niveles de factor de coagulación XI.
Conclusiones:
- Se confirmó que las variaciones genéticas comunes juegan un papel importante en la determinación de la susceptibilidad de un individuo a la TVP.
- Se destacaron genes específicos y SNPs que contribuyen al riesgo trombótico, ofreciendo objetivos potenciales para futuras investigaciones.
- Demostró un vínculo entre las variaciones genéticas en la región CYP4V2, la TVP y los niveles de factor XI.
Videos de Conceptos Relacionados
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:26Varicose Veins I: Introduction
Varicose veins, or varicosities, are abnormally dilated and twisted superficial veins caused by venous valve incompetence. This condition commonly affects the lower extremities, especially the saphenous veins, due to the higher pressure from prolonged standing and walking. However, varicosities can also occur in other areas, such as the esophagus, vulva, spermatic cords, and anorectal region.Etiology and typesPrimary varicose veins, often idiopathic, are more common in women due to inherent...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...